efavirenz

Ukraine

Drugs containing this active substance

  • EFAVIRENZ

    The drug is used as part of combination therapy to treat infection caused by the human immunodeficiency virus (HIV-1) in adults and children aged 3 years and older.

    Form: tablets, film-coated

    Active substance Dosage
    efavirenz 200 mg

    ATC: J05AG03

    Manufacturer: StridePharma Science Limited

  • The drug is used as part of combination therapy to treat infection caused by the human immunodeficiency virus (HIV-1) in adults and children aged 3 years and older.

    Form: tablets, film-coated

    Active substance Dosage
    efavirenz 600 mg

    ATC: J05AG03

    Manufacturer: StridePharma Science Limited

  • Efavirenz, lamivudine and tenofovir disoproxil fumarate is indicated for the treatment of HIV infection (human immunodeficiency virus type 1) in adults and children aged 10 years and older weighing more than 35 kg.

    Form: tablets, film-coated

    Active substance Dosage
    efavirenz 600 mg
    lamivudine 300 mg
    tenofovir disoproxil 245 mg

    ATC: J05AR11

    Manufacturer: Macleods Pharmaceuticals Limited

  • This drug is a combination therapy for the treatment of HIV infection (human immunodeficiency virus type 1) in adults and adolescents aged 10 years and older weighing at least 35 kg.

    Form: tablets, film-coated

    Active substance Dosage
    efavirenz 600 mg
    emtricitabine 200 mg
    tenofovir disoproxil fumarate 300 mg

    ATC: J05AR06

    Manufacturer: StridePharma Science Limited

  • The drug is used as part of combination therapy for the treatment of diseases caused by the human immunodeficiency virus (HIV-1) in adults and children weighing 40 kg or more.

    Form: tablets, film-coated

    Active substance Dosage
    efavirenz 600 mg

    ATC: J05AG03

    Manufacturer: San Pharmaceutical Industries Limited

  • The drug is used as a full treatment regimen for human immunodeficiency virus type 1 (HIV-1) infection in adults and children weighing at least 35 kg.

    Form: tablets, film-coated

    Active substance Dosage
    efavirenz 400 mg
    lamivudine 300 mg
    tenofovir disoproxil fumarate 300 mg

    ATC: J05AR11

    Manufacturer: Hetero Labs Limited

  • The drug is used as part of combination therapy for the treatment of diseases caused by the human immunodeficiency virus (HIV-1) in adults, adolescents, and children weighing 40 kg or more.

    Form: tablets, film-coated

    Active substance Dosage
    efavirenz 600 mg

    ATC: J05AG03

    Manufacturer: Hetero Labs Limited

  • The drug is intended for the treatment of HIV infection (human immunodeficiency virus type 1) in adults aged 18 years and older who are already receiving antiretroviral therapy and have a blood virus level of less than 50 copies/ml.

    Form: tablets, film-coated

    Active substance Dosage
    efavirenz 600 mg
    emtricitabine 200 mg
    tenofovir disoproxil fumarate 300 mg

    ATC: J05AR06

    Manufacturer: Hetero Labs Limited